Agenus Inc. (AGEN)
NASDAQ: AGEN · Real-Time Price · USD
3.430
+0.230 (7.19%)
At close: May 30, 2025, 4:00 PM
3.320
-0.110 (-3.21%)
After-hours: May 30, 2025, 7:48 PM EDT
Agenus Employees
Agenus had 316 employees as of December 31, 2024. The number of employees decreased by 73 or -18.77% compared to the previous year.
Employees
316
Change (1Y)
-73
Growth (1Y)
-18.77%
Revenue / Employee
$314,949
Profits / Employee
-$603,820
Market Cap
94.04M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
AGEN News
- 1 day ago - Agenus Presents New Data at ASCO Highlighting Botensilimab's Immune Activation in MSS Colorectal Cancer - Business Wire
- 8 days ago - Agenus: Big On BOT/BAL As Cash Burn And Catalysts Collide - Seeking Alpha
- 16 days ago - Agenus Announces New Data from Expanded MSS Metastatic Colorectal Cancer Cohort to be Presented at ESMO GI 2025 - Business Wire
- 19 days ago - Agenus Inc. (AGEN) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 19 days ago - Agenus Reports Q1 2025 Financial Results and Key Business Updates - Business Wire
- 19 days ago - Renowned GI Oncology Leader Dr. Richard Goldberg Joins Agenus as Chief Development Officer - Business Wire
- 4 weeks ago - Agenus to Provide Corporate Update and First Quarter 2025 Financial Report - Business Wire
- 4 weeks ago - Agenus' BOT/BAL Neoadjuvant Pan-Cancer Data from the NEOASIS Study Presented in an Oral Session at AACR - Business Wire